Responses
Cardiovascular medicine
Research
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database
Compose a Response to This Article
Other responses
No responses have been published for this article.